S-1 FILED · JUNE 1, 2026

The AI Lab Pre-IPO Stack 2026

Every foundation-model lab heading toward public markets — Anthropic leads at $965B with a confidential filing in hand, OpenAI targets Q4, xAI hits $230B. Six companies, $2.5T+ combined valuation, the largest AI IPO wave in history.

6
AI Labs Tracked
$2.5T
Combined Valuation
1
S-1 Filed (Anthropic)
Q4 '26
First Listing Target
// THE STACK

Six AI labs. Six IPO timelines.

Ranked by IPO readiness — combining S-1 progress, revenue scale, lead underwriter commitment, and revenue trajectory. Updated July 22, 2026.

Company
IPO Readiness
Valuation
Revenue
Status
01
A
Anthropic
Claude · AI Safety
94/100
$965B
$47B ARR
S-1 Filed
02
O
OpenAI
ChatGPT · GPT-5
87/100
$852B
$13B ARR
For-Profit
03
X
xAI
Grok · Colossus
81/100
$230B
$2.5B est.
H2 '26 Target
04
M
Mistral AI
Open Weights · EU
68/100
€11.7B
€80M est.
2027 Target
05
C
Cohere
Enterprise NLP
54/100
$6.8B
$200M est.
2027+
06
S
SSI
Superintelligence · No Revenue
29/100
$32B
$0
No IPO
// FIVE THEMES DRIVING THE STACK

Foundation-model consolidation, AI infra gravity, and the inference-vs-training split.

Each of these themes is materially reshaping how the AI Lab Stack is valued heading into the 2026-2027 listing window.

// 01
Foundation-model consolidation is real — and it kills second-tier valuations.
With Anthropic, OpenAI, and xAI absorbing 90%+ of AI compute spend, mid-tier labs (Cohere, Mistral, SSI) are seeing secondary tender compression. The 2027 IPO class will likely be only Anthropic, OpenAI, and xAI — Mistral, Cohere, and SSI face exits via M&A or down-rounds.
// 02
The "inference-as-margin" reframe.
Anthropic's reported $47B ARR (May 2026) is ~70% API inference revenue — not training contracts. Public-market investors price inference revenue at 12-18x multiples vs 4-6x for training/services. This is why Anthropic's valuation ($965B) outpaces OpenAI ($852B) despite OpenAI's larger user base.
// 03
The Anthropic-vs-OpenAI operating-profit inflection.
Anthropic reported first operating profit in Q2 2026 ($559M). OpenAI reportedly hit operating profit in Q1 2026. Both departures from pure-loss growth narrative change the public-market framing from "burn-multiple stories" to "hyperscaler comps." Microsoft, Google, and Amazon trading multiples apply.
// 04
Compute capex is the new risk factor.
xAI's Colossus supercomputer ($30B+ cumulative buildout by Q4 2026) and Anthropic's Project Rainforest ($50B AWS + Google expansion through 2027) mean these IPOs will carry high capex sensitivities. Expect investor questions on Model TCO vs compute depreciation on every earnings call.
// 05
The retail allocation question — who actually gets shares?
Anthropic's October IPO is reported at ~25% retail allocation — 2-3x standard mega-cap IPOs. OpenAI's rumored structure (potential direct listing or dual-class) may yield different access. xAI's Tesla/SpaceX retail overlap is non-trivial. Retail investors should expect IPO-day FOMO followed by 90-day lockup unlock selling pressure.
// 06
Secondary markets are mostly dead for AI labs.
Anthropic voided all secondary trades on Forge Global and Hiive on May 11, 2026. OpenAI has restricted undocumented secondary flows. For accredited investors, EquityZen still lists the occasional Anthropic tender. For non-accredited: wait for the IPO.
// IPO TIMELINE

Three listings expected in the next 12 months.

Anthropic first (Oct 2026), OpenAI next (Q4 2026 or Q1 2027), xAI last (late 2026 or early 2027). Dates below track public reporting and analyst consensus as of July 22, 2026.

Oct 2026 — CONFIRMED TARGET
Anthropic IPO — Nasdaq or NYSE, ticker "ANTH"
Confidential S-1 filed June 1. Goldman Sachs + JPMorgan + Morgan Stanley reported as lead underwriters. Targeting October listing with $75-100B raise at $965B+ valuation. Retail allocation expected at 20-30%. S-1 amendments will become public late July / early August.
Q4 2026 — STRONG CONSENSUS
OpenAI IPO or Direct Listing
For-profit restructure (PBC) completed October 2025. Working timeline from internal sources points to Q4 2026 or Q1 2027 listing. Lead underwriter rumored to be Morgan Stanley with Goldman Sachs + JPMorgan in syndicate. Ticker "OPAI" (not yet confirmed). Likely $60-80B raise.
H2 2026 / H1 2027 — TARGET
xAI Combined-Entity Listing
May 2026 Series E raised $20B at $230B valuation. Requires corporate restructuring to merge X (formerly Twitter) into xAI before listing. Elon Musk has signaled late 2026 to early 2027 listing window. TBD on whether standalone xAI or combined entity.
2027 — TARGET
Mistral AI (Euronext Paris)
European listing on Euronext Paris most likely. Target H2 2027. Would be the first major AI foundation model lab to list in Europe. Open-weight model strategy and EU AI Act positioning create unique narrative.
2027+ — UNDETERMINED
Cohere, SSI, others
Cohere's IPO timing dependent on revenue growth (currently ~$200M ARR). SSI's $32B valuation with zero revenue makes public markets highly unlikely before 2028. Expect M&A scenarios: Cohere→Oracle or Salesforce, SSI→Google DeepMind absorption.

Want the AI Lab Stack file + live S-1 amendments?

S-1 amendment alerts, secondary-market tender notifications, and the full pre-IPO valuation model for all 6 AI labs — in one Stack file.

Get the AI Lab Stack →
// RELATED STACKS

Beyond the labs — the rest of the 2026 AI IPO market.

ADJACENT STACK
AI Infrastructure Pre-IPO Stack 2026
Databricks ($134B), Cursor ($50B+), Cerebras, Groq, Together AI
SECTOR STACK
Chips Pre-IPO Stack
Cerebras (now CBRS), Groq, Tenstorrent, SambaNova, Lightmatter
BROADER STACK
Top Pre-IPO AI Companies 2026
All 80+ AI companies tracked across model, infra, and applications layers
COMPANY PAGE
Anthropic Pre-IPO Analysis
Full S-1 analysis, underwriters, valuation history, investor access paths
// ANSWER ENGINE OPTIMIZATION

The questions investors actually ask.

Six questions our team fields most often from accredited and retail investors in July 2026. Sources cited inline.

Q1
Which AI lab files S-1 next?
OpenAI. The for-profit restructure cleared in Q4 2025. Working timeline from internal sources: Q4 2026 S-1 filing, Q1 2027 listing. xAI's combined-entity restructure is the second-most likely filing in the next 6 months.
Q2
How does Anthropic's revenue compare to OpenAI?
Anthropic $47B annualized run-rate (May 2026) vs OpenAI $13B (late 2025). Anthropic grew 5x in 5 months. OpenAI's revenue is ~75% consumer / ChatGPT subscription. Anthropic's is ~70% enterprise API. Different businesses, different multiples.
Q3
Is xAI actually profitable on a unit basis?
Not in any GAAP sense. xAI reported $2.5B estimated 2026 revenue against $30B+ cumulative compute capex. Elon Musk has publicly stated profitability is "2-3 years out." Public-market investors should expect revenue scale story, not margin story.
Q4
Can I buy OpenAI pre-IPO tender?
Yes — through EquityZen, but with restrictions. OpenAI has restricted direct on-platform transfers; EquityZen works through a tender offer structure approved by OpenAI's general counsel. Minimum investment typically $50,000. Avoid platforms claiming OpenAI secondary outside tender flows — most are unauthorized.
Q5
What's the Anthropic IPO allocation for retail?
Reported at 20-30% retail allocation, on the high end for mega-cap IPOs. Brokerage access: Charles Schwab, Fidelity, Robinhood, SoFi Securities all expected. IPO date target: October 2026. Lockup: standard 180 days for insiders. Retail dilution risk at lockup unlock March-April 2027.
Q6
Mistral — worth a 2027 Paris listing?
Depends on revenue trajectory. Current €80M ARR against €11.7B valuation = ~146x ARR. Comparable US AI labs trade at 40-90x forward ARR. Mistral would need to 3x revenue by mid-2027 to defend valuation at IPO. The EU AI Act tailwind and open-weight model positioning could justify a premium but not 146x.